| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |